Senjuty Sarkar

Paediatric rheumatology is that medicine dedicated to the diagnosing and treatment of inflammatory illnesses of the system and alternative reaction diseases in children. They need their characteristics in terms of symptoms, diagnosis, treatment and prognosis. During the 2019 Coronavirus Pandemic (COVID19), healthcare providers were forced to change their treatment. Various providers have shifted from observing patients in front of their eyes to using telemedicine platforms with limited training and the ability to use the environment. This is more difficult because interviews with doctors usually require a positive evaluation of the patient. In paediatric rheumatology, this was additional difficult as they usually need active assessment of patients.

A probe was conducted to look at the adoption of telemedicine into paediatric rheumatology practices, to assess its edges and challenges, and to collect opinions on its continuing use. A survey was sent to the lead representatives of the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) to collect information concerning their centre' expertise with telemedicine throughout the COVID-19 pandemic. Quantitative data were thematically analyzed using descriptive statistics and qualitative data. Responses were received from the bulk [19/21 (90%)] of the COIN sites. All respondents said they had switched from face-to-face to mostly virtual patient visits during the COVID19 pandemic. All centres reported having seen every new consultation and patient follow-up via telemedicine. Most centres reported using audio and video conferencing systems to conduct their telemedicine visits. The bulk of respondents [13/19 (68%)] indicated that a minimum of 50% of their site' suppliers systematically used paediatric rheumatology to perform active joint count assessments over telemedicine. Concerning patient adoption of telemedicine, another study in pediatric medicine reported that, although 28% of clinic patients travelled to examine their pediatric rheumatology providers.

Most (95%) patients reported a preference for in-person clinical visits rather than telemedicine visits. The COVID-19 pandemic forced patients as well as paediatric rheumatology providers, to speedily shift to virtual care.

The apply of telemedicine expedited uninterrupted medical aid whereas lasting by physical distancing requirements. The forced, facilitated adoption of telemedicine across pediatric rheumatology clinics came with its challenges. The popularity of those challenges and barriers prompts the identification of potential solutions that may improve future delivery of care over telemedicine.

The target of this study was to look at the adoption of telemedicine into pediatric rheumatology practices throughout the COVID-19 pandemic, to assess its edges and challenges, and to collect opinions on its continuing use. Nearly 66% of pediatric rheumatology suppliers reportable telemedicine visits were inadequate for full clinical assessments, whereas 35.8% felt their level of burnout had exaggerated as a result of telemedicine, per the survey results. Solely by understanding the way to optimally use technological tools clinicians will improve the delivery of medical take care of patients with chronic illness. Telemedicine in pediatric rheumatology care can function as a model for alternative pediatric subspecialties requiring chronic disease management by more improvement.